Medlive Technology Co (HKSE:02192) Buyback Yield % : -0.03 (As of Apr. 30, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Medlive Technology Co's current buyback yield was -0.03%.

Medlive Technology Co Buyback Yield % Historical Data

The historical data trend for Medlive Technology Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co Buyback Yield % Chart

Medlive Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

-25.41

-0.09

-0.03

Medlive Technology Co Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Buyback Yield %	Get a 7-Day Free Trial							-	-	-0.09	-	-0.03

Competitive Comparison of Medlive Technology Co's Buyback Yield %

For the Health Information Services subindustry, Medlive Technology Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlive Technology Co's Buyback Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Medlive Technology Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Medlive Technology Co's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	2.399)	/	7277.45868
	=	-0.03%

Medlive Technology Co's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	2.399)		/	7277.45868
	=	-0.03%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Medlive Technology Co Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlive Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medlive Technology Co Ltd (HKSE:02192) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Huangqu East Road No. 5, Courtyard Building 4, Yimaitong Mansion, Chaoyang District, Beijing, CHN

Website

https://www.medlive.cn

Medlive Technology Co Ltd is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms. The company developed into a professional provider of medical information services and precision digital marketing services. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that helps with medical conferences and clinical research.

Executives

Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng	2101 Beneficial owner
Liu Lingdi	2101 Beneficial owner
Tian Lixin	2101 Beneficial owner
Tiantian Co., Limited
M3, Inc.	2101 Beneficial owner
Sony Group Corporation	2201 Interest of corporation controlled by you
Brown Brothers Harriman & Co.	2502 Approved lending agent
Fidelity Funds	2101 Beneficial owner

Medlive Technology Co Headlines

No Headlines